Results 71 to 80 of about 34,165 (229)

The ectonucleotidase cd39/ENTPDase1 modulates purinergic-mediated microglial migration

open access: yes, 2008
Microglia is activated by brain injury. They migrate in response to ATP and although adenosine alone has no effect on wild type microglial migration, we show that inhibition of adenosine receptors impedes ATP triggered migration.
Gertz, K.   +23 more
core   +1 more source

CD39 as a metabolic rheostat of immunoregulation

open access: yesCellular & Molecular Immunology
L. Zhang et al. proposed novel immunotherapeutic strategies to limit the progression of inflammatory bowel diseases by targeting the interplay between the membrane-bound CD39 molecule and cellular metabolism — specifically, by increasing regulatory T-cell function through the modulation of glucose metabolism and suppressing pathogenic proinflammatory ...
Barnaba, Vincenzo, Sozzani, Silvano
openaire   +2 more sources

Clinical predictors of response to methotrexate in patients with rheumatoid arthritis: A systematic review

open access: yesRheumatology &Autoimmunity, EarlyView.
This review integrates clinical, immunological, genetic, and multi‐omic evidence, highlighting dynamic inflammatory and adenosine‐pathway biomarkers and reinforcing treat‐to‐target principles as the most actionable framework for personalized methotrexate therapy.
Joana Ramos Rodrigues   +6 more
wiley   +1 more source

High circulating CD39+ regulatory T cells predict poor survival for sepsis patients

open access: yesInternational Journal of Infectious Diseases, 2015
Background: Sepsis encompasses two phases, the ‘hyper’-reactive phase and the ‘hypo’-reactive phase. The initial inflammatory stage is quickly counterbalanced by an anti-inflammatory response, which compromises the immune system, leading to immune ...
Huihuang Huang   +14 more
doaj   +1 more source

Treg‐stromal cell axis in tissue repair and autoimmune diseases: Mechanisms and clinical translation

open access: yesRheumatology &Autoimmunity, EarlyView.
The Treg‐stromal cell axis as a central regulator of tissue repair and immune tolerance. Under physiological conditions, bidirectional communication between Tregs and stromal cells—mediated by cell‐surface molecular contacts, anti‐inflammatory cytokines, and extracellular vesicles—orchestrates inflammation resolution, immune tolerance, and complete ...
Peiyan Zhang   +2 more
wiley   +1 more source

Abundance of CD73 and CD39 on leukocytes in blood and heart under basal conditions.

open access: yes, 2013
A: CD73+ and CD39+ cells per leukocyte population in cardiac tissue. B: CD73/CD39 surface density on CD73+/CD39+ cells per leukocyte population in cardiac tissue. C: CD73+ and CD39+ cells per leukocyte population in blood. D: CD73/CD39 surface density on
Nadine Borg (326505)   +3 more
core   +1 more source

Current Advances of Treatments, Therapeutic Targets, Biomarkers, Novel Drugs, and Machine Learning for Hypopharyngeal Squamous Cell Carcinoma

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Hypopharyngeal squamous cell carcinoma (HSCC) is an aggressive subtype of head and neck squamous cell carcinoma with insidious onset, early metastasis, and dismal prognosis. Conventional multimodal therapy achieves limited survival benefit, highlighting an urgent need for refined precision strategies.
Ce Li   +12 more
wiley   +1 more source

Impact of CD39 expression on CD4+ T lymphocytes and 6q deletion on outcome of patients with chronic lymphocytic leukemia

open access: yesHematology/Oncology and Stem Cell Therapy, 2019
Objective/Background: Chronic lymphocytic leukemia is one of the commonest leukemias affecting adults. CD39 inhibits T-cell and Natural killer (NK) cell responses by hydrolyzing adenosine triphosphate and adenosine diphosphate, suppressing the immune ...
Eman Mosaad Zaki   +5 more
doaj   +1 more source

High-dimensional analysis of the adenosine pathway in high-grade serous ovarian cancer

open access: yesJournal for ImmunoTherapy of Cancer, 2021
Background Hydrolysis of extracellular ATP to adenosine (eADO) is an important immune checkpoint in cancer immunology. We here investigated the impact of the eADO pathway in high-grade serous ovarian cancer (HGSC) using multiparametric platforms.Methods ...
John Stagg   +13 more
doaj   +1 more source

Targeting CD39 in cancer reveals an extracellular ATP- and inflammasome-driven tumor immunity

open access: yes, 2019
We explored the mechanism of action of CD39 antibodies that inhibit ectoenzyme CD39 conversion of extracellular ATP (eATP) to AMP and thus potentially augment eATP-P2-mediated proinflammatory responses.
Robson, Simon C.   +69 more
core   +1 more source

Home - About - Disclaimer - Privacy